- Correction
- Open access
- Published:
Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Acta Neuropathologica Communications volume 12, Article number: 110 (2024)
The Original Article was published on 16 November 2019
Correction to: Acta Neuropathologica Communications (2019) 7:183 https://doi.org/10.1186/s40478-019-0836-x
Following publication of the original article [1], the authors identified an error in Figure 2. Figure 2 had a duplicated image panel.
The duplicated images represented a figure design error and do not impact interpretation of the manuscript.
The incorrect Figure 2:
Prevalence of tau pathology in LRRK2 mutation carriers. Seven brain regions from 12 individuals carrying LRRK2 mutations were evaluated by staining for pathological pS202/T205 tau (AT8). Of the 12 cases, 10 showed prominent pathological tau, including in the hippocampus, while 2 cases had minimal pathological tau present. Scale bar = 100 µm
The correct Figure 2:
Prevalence of tau pathology in LRRK2 mutation carriers. Seven brain regions from 12 individuals carrying LRRK2 mutations were evaluated by staining for pathological pS202/T205 tau (AT8). Of the 12 cases, 10 showed prominent pathological tau, including in the hippocampus, while 2 cases had minimal pathological tau present. Scale bar = 100 µm
The correct Figure 2 has been indicated in this correction article and the original article [1] has been corrected.
Reference
Henderson MX, Sengupta M, Trojanowski JQ et al (2019) Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease. Acta Neuropathol Commun 7:183. https://doi.org/10.1186/s40478-019-0836-x
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Henderson, M.X., Sengupta, M., Trojanowski, J.Q. et al. Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease. acta neuropathol commun 12, 110 (2024). https://doi.org/10.1186/s40478-024-01819-7
Published:
DOI: https://doi.org/10.1186/s40478-024-01819-7